서은진
서은진 Shared 4/25/2026 12:35 PM
English Public Current voice ready

Pharm FLASH CARD : Cardiovascular VOCA 1(15P~)

Current voice
Ready to listen

Play the current voice and follow the practice script on the same page.

Type audio/mpeg
Length 204.6 s
Voice Ryan
Created 4/25/2026 12:47 PM
Total length 3:24
0:00 3:24
Playback speed 1.00x
Repeat playback Off
Repeat time Off
Sentence repeat count 2
Pause between sentences 1.00 s

Repeat playback is off.

Line-by-line highlighting is ready for this audio.

Create Account

Create account to choose voice and language

Audio Mate supports many different voices and languages. Create an account to explore and save your preferred voice and language choices.

Practice script

When timing data is available, the current line is highlighted while audio plays.

1. Antihypertensive Medications
A ACE Inhibitors :lisinopril, enalapril
A ARBs :losartan, valsartan
B Beta Blockers :metoprolol, atenolol
C Calcium Channel Blockers :amlodipine, nifedipine
D Diuretics : furosemide, HCTZ, spironolactone
2.Orthostatic Hypotension :Low blood pressure that occurs due to a position change from lying down or sitting to standing up.
3. Orthostatic Hypotension Causes
: ACE inhibitors / ARBs: ACE 억제제 및 안지오텐신 수용체 차단제
Beta blockers: 베타 차단제
Calcium channel blockers: 칼슘 채널 차단제
Diuretics (all types): 이뇨제 (모든 종류)
Nitroglycerin & vasodilators: 니트로글리세린 및 혈관 확장제
Adenosine: 아데노신
Antianginal drugs: 항협심증 약물
PLUS dehydration & loss of body fluid!: ACE inhibitors / ARBs: ACE 억제제 및 안지오텐신 수용체 차단제
Beta blockers: 베타 차단제
Calcium channel blockers: 칼슘 채널 차단제
Diuretics (all types): 이뇨제 (모든 종류)
Nitroglycerin & vasodilators: 니트로글리세린 및 혈관 확장제
Adenosine: 아데노신
Antianginal drugs: 항협심증 약물
PLUS dehydration & loss of body fluid!:ACE inhibitors / ARBs: ACE 억제제 및 안지오텐신 수용체 차단제
Beta blockers: 베타 차단제
Calcium channel blockers: 칼슘 채널 차단제
Diuretics (all types): 이뇨제 (모든 종류)
Nitroglycerin & vasodilators: 니트로글리세린 및 혈관 확장제
Adenosine: 아데노신
Antianginal drugs: 항협심증 약물
PLUS dehydration & loss of body fluid!:추가로 탈수 및 체액 손실도 원인이 됨!

There is no feedback yet.